The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bought some on Friday @ 16.10p so actually happy with that. I'm thinking a higher opening this morning at least. Obviously fuelled by media coverage, optimism and speculation surrounding a possible future bid from multiple interested parties. Will acquire some for my SIPP this morning, but at what price?. Don't actually care because they can just sit and wait quietly for true value to be achieved this year/next year. PS was here many moons ago and remember selling @ 108p. Didn't actually make a fortune as i remember buying @ 80p approx. Still, all good 👍👍. :o).
Hopefully in the mid twenties tomorrow. More RNs to drop. Looking very good
Gutted, but that's fine. As long as it stays low, I'll buy back for 50p target. Hopefully will be sun 20p Tuesday. Otherwise, first dip, I'll be back in.
The press coverage has been great for the company
Finally something to look forward to on Tuesday....
"This time next year we'll be millionaires"...
That's the Mail - who has the Times article to hand?? Feels like a leap into the 20s possible on Tuesday?
Nov 2022 to Jan 2023. No more shares have been issued.
I see no reason why the sp could not re-rate to around 50p a share in view of the recent fantastic news.
All IMHO.
I paid similar and thought it was still undervalued at £1.50 so held !
Lets see where it goes.....
Deepest sympathies Mercadooly. Tough, tough, tough... Let's pray for everyone's sakes this now moves fast.
So you will not find trial protocol etc
It’s a private study that involves Parsortix NHS in four cancer indications. 1000 subjects
Please explain?
Https://twitter.com/UroResearchNBT/status/1783071359800676823
thanks to 's****y' advfn
https://twitter.com/tymeric7/status/1786680910781272521
We have dragged our feet for some reason fo a long time. This was showing good results years ago. Out of support I paid £1 , never left. Now waiting for its true value.
Some people have died using the older test system. My son for one. Mist that he had an infection,
Actually made about 8" column in the Times today
Apologies if already posted..
https://www.thetimes.co.uk/article/astrazeneca-contract-puts-angle-in-spotlight-kwgj8s5j0
EC
I am not sure if there are any shorts on this position but stand corrected if products are now available.
LOL! Up 29% now.
So, did you have a short position?
Did you close it today?
Pray tell.
Results soon will tell us the true story...
- Providing Angle can deliver the goods
How many millions of women/men go through stress of biopsies this advance technology moves away from this dangerous procedure, in turn stopping infections. Andrew talks of income upto £45mil just for prostrate numbers with one pharmaceutical company. Do the maths when others sign and all the other cancers are introduced. The numbers are beyond belief.
Angle have more trials at the same stage Breast, cervical, rectal they will all be introduced at some stage. Grab a bargain SP has been over £1.10 before any top pharmaceutical sign up’s
Actually i am sure sure that’s quite right.
I have no doubt Newland tries to pump the price up regularly with zero content announcements. And i have been ultra-negative on him. But if this is what it purports to be it has potential to be quite significant.
But now he’s actually announced three contracts. Small maybe - but signs that there is real commercial interest.
Anyway that was enough for me to put a toe ( no more ) back in the water.
I am sure there will be an equity issue. But if he keeps these coming it will be off a much higher price.
My remaining concern is he has alienated all the Institutional holders - but we will see.
Rolling in, including the one today with Astrazeneca for over half a million £.
Shorters want holders to sell.
Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. Cash call may NOT be needed................
All IMHO.
How thoughtful of astra zeneca to be so obliging